Cerus price to free cash flow CERS

Market value divided by free cash flow over the last twelve months, since 2025.

Today, Oct 23, 2026: n/m; not a meaningful number
Last meaningful: 343×; Apr 2026
Peer median: 16.7×

Cerus' price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.

It was last meaningful in Apr 2026, at 343×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	343×	293×	361×
2025	82.3×	27.0×	89.6×

Against its peers

Companies in Medical - Instruments & Supplies nearest Cerus' size, closest first, today.

Company	Price to free cash flow
CERSCerus	n/m
TCMDTactile Systems Technology	20.0×
MDXGMimedx	n/m
EMBCEmbecta	2.3×
MOVMovado	9.8×
INFUInfuSystem	12.1×
UTMDUtah Medical Products	20.6×
IRMDIradimed	43.7×
PDEXPro DEX	29.5×
STAAStaar Surgical	n/m
BVSBioventus	13.3×
Peer median	16.7×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Cerus

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.